VIDEOS

FAID 2016 Presentations - Please return soon for additional content

DAY 1

  1. 1
    Carnot Institutes: Research & Innovation for Industry and RTOs / Pascal Deschaseaux, VP Ai Carnot, General Manager, CALYM

Session 1 "Big Data in Clinical Trials: From Integrated Patients Profile to Complex Biomarkers”

  1. 1
    A Multidimensional Contribution to Personalized Medicine in Lymphoma / Gilles Salles, Chairman, CALYM

  2. 2
    Michel Meignan, Professor of Nuclear Medicine, Henri Mondor University Hospital

  3. 3
    Peter Ho, CMO, Epizyme Inc

  4. 4
    Imaging as Analysis Tool and Biomarker / Pierre Tervé, VP Technic & Scientific Advisor, Keosys

  5. 5
    A Virtual Laboratory for Image-based Neuroscience Discovery: Collaborative Research and Science Education in the Era of “Big Data” / Charles R.G. Guttmann, Director, Center for Neurological Imaging, Brigham & Women’s Hospital, Associate Professor of Radiology, Harvard Medical School

  6. 6
    Big Data Analytics for Acute Patient Care / Hans-Aloys Wischmann, Head of Philips Research North America

  7. 7
    Next Generation of Clinical Trials in Oncology / Christophe Le Tourneau, Head of Early Trials, Institut Curie

  8. 8
    Bridging Basic and Translational Research in Tumor Immunology for the Benefit of Cancer Patients / Emanuela Romano, Head of Immunotherapy Unit, Institut Curie

  9. 9
    Squeezing Water from a Stone: Urine as a Biospecimen for RNA-based Biomarker Discovery / Jill A. Macoska, Director, Center for Personalized Cancer Therapy, University of Massachusetts, Boston

DAY 2

Session 2 "From Integrated Business Models to New Funding Strategies for Early Stage R&D”

  1. 1
    Keynote Address – The Institut Pasteur, a New Innovation Model / Christian Bréchot, President, Institut Pasteur

  2. 2
    Harrington Project / Jonathan Stamler, Director, Harrington Discovery Institute

  3. 3
    From Academe to Startup: The Journey of an Entrepreneur at UCSF / Stephanie Marrus, Director, Entrepreneurship Center, University of California, San Francisco (UCSF)

  4. 4
    Panel III – New Business Models of Innovation

  5. 5
    Success Story: A Relevant Model for Academia-Industry R&D Partnerships / Gilles Salles, Chairman, CALYM

  6. 6
    Success Story: Biological Integrated Approaches for Drug Development / Sergio Roman-Roman, Head of Translational Research, Institut Curie


Session 3 "Rare Diseases: Models and Opportunities”

 

  1. 1
    Rare Diseases: Models and Opportunities / Yves Agid, Founder & Scientific Advisor, ICM

  2. 2
    Rare Diseases: Models and Opportunities / Fanny Mochel, Head of Metabolic Research Group, ICM

  3. 3
    Gene-indepedant therapies in genetic retinal degenerations / José-Alain Sahel, Founder & Director, Institut de la Vision

  4. 4
    Rare Diseases: Models and Opportunities / Michel Vellard, VP of Research, Ultragenyx

  5. 5
    Gerry Cox, VP Clinical Development Rare Diseases Group, Genzyme, a Sanofi Company

  6. 6
    Panel IV – Rare Diseases: Models and Opportunities

  7. 7
    Keynote Address – Moderna: Pioneering Clinical Messenger RNA Therapeutics / Stéphane Bancel , CEO, Moderna Therapeutics

Session 4 "Transforming Clinical Research: New End-Points and Regulatory Renewal”

 

  1. 1
    José-Alain Sahel, Founder & Director, Institut de la Vision

  2. 2
    Newton Howard, Chairman, Brain Sciences Foundation

  3. 3
    Nahid Bhadelia, Infectious Diseases Physician, Boston University School of Medicine, Director of Infection Control and Medical Response National Emerging Infectious Diseases Laboratories

FAID 2016 Interviews - Please return soon for additional content

  1. Chris Adams, CEO & Co-Founder, Ceeable

  2. Nahid Bhadelia, MD, MA, Director of Infection Control and Medical Response, National Emerging Infectious Diseases Laboratories

  3. Christian Bréchot, MD, PhD, President of Institut Pasteur

  4. Erwan Corcuff, CEO, Axenis

  5. Pascal Deschaseaux, MD, MBA, General Manager of CALYM, VP Association des Instituts Carnot

  6. Peter Ho, MD, PhD, CMO, Epizyme Inc

  7. Daniel Larzul, PhD, Coordinator of the GLOBAL CARE Initiative, Deputy Executive Vice President Development, Institut Pasteur

  8. Christophe Le Tourneau, MD, PhD, Head of Early Trials, Institut Curie
  9. Jill A. Macoska, PhD, Director of the Center for Personalized Cancer Therapy, UMass Boston

  10. Samir Medjebar, PharmD, MBA, COO, Ad Scientiam

  11. Michel Meignan, MD, PhD, Professor of Nuclear Medicine, Henri Mondor University Hospital

  12. Fanny Mochel, MD, PhD, Head of Metabolic Research Group, ICM

  13. Sergio Roman-Roman, PharmD, PhD, Head of Translational Research, Institut Curie

  14. Jonathan Stamler, MD, Director of the Harrington Discovery Institute

  15. Hans-Aloys Wischmann, PhD, Head of Philips Research North America

  16. Pierre Tervé, VP Technic & Scientific Advisor, Keosys